Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Compass Therapeutics, Inc. Common Stock

CMPX Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of CMPX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
CMPX Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
CMPX Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
CMPX Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in CMPX holdings by institutional investors

Quarterly net insider trading by CMPX's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $80,000 Oct 20, 2025 Issue: Health Issues

Former government officials who have lobbied for CMPX

Quiver Logo

No former government officials on record as having lobbied for CMPX

Revolving Door Dashboard

CMPX Estimated quarterly lobbying spending

CMPX Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
CMPX Income Statement
CMPX Balance Sheet
CMPX Cash Flow
U.S. Patents

New CMPX patent grants

  • Patent Title: Multispecific binding constructs against checkpoint molecules and uses thereof Dec. 23, 2025
  • Patent Title: Transgenic mouse expressing common human light chain Nov. 11, 2025
  • Patent Title: Antibodies that bind cd277 and uses thereof Nov. 04, 2025
  • Patent Title: Method of treating cancer using cd137 antibodies and pd-1 antagonists Apr. 29, 2025
  • Patent Title: Multispecific binding constructs against checkpoint molecules and uses thereof Apr. 30, 2024
  • Patent Title: Cd137 antibodies and tumor antigen-targeting antibodies and uses thereof Dec. 26, 2023
  • Patent Title: Agonist antibodies that bind human cd137 and uses thereof Sep. 12, 2023
  • Patent Title: Cd137 antibodies and pd-1 antagonists and uses thereof Aug. 08, 2023
  • Patent Title: Multispecific binding constructs against checkpoint molecules and uses thereof Jun. 29, 2021
  • Patent Title: Agonist antibodies that bind human cd137 and uses thereof Jul. 21, 2020
  • Patent Title: Agonist antibodies that bind human cd137 and uses thereof Oct. 08, 2019
  • Patent Title: Agonist antibodies that bind human cd137 and uses thereof Jul. 16, 2019
  • Patent Title: Agonist antibodies that bind human cd137 and uses thereof May. 07, 2019
  • Patent Title: Agonist antibodies that bind human cd137 and uses thereof May. 07, 2019
  • Patent Title: Agonist antibodies that bind human cd137 and uses thereof May. 07, 2019
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to CMPX from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
CMPX News

Recent insights relating to CMPX

CNBC Recommendations

Recent picks made for CMPX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CMPX

CMPX Analyst Ratings

CMPX Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
CMPX Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $CMPX stock a Buy, Sell, or Hold?

  • What is the price target for $CMPX stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

CMPX Top Shareholders
Shareholder
Shares Held
CMPX Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $CMPX stock?

  • Who owns the most shares of $CMPX stock?

  • What funds own $CMPX stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

CMPX Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view CMPX Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About CMPX

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

  • Address Boston, MA
  • Market Cap 210.7 million
  • Employees 39
  • Industrial Classification Biological Products, (No Diagnostic Substances)

Compass Therapeutics, Inc. Common Stock (CMPX) Historical Stock Prices

Compass Therapeutics, Inc. Common Stock (CMPX) closed at $1.17 on September 23, 2026. Over the past year its adjusted close ranged from $1.17 to $6.69. Daily prices go back to April 5, 2021, 1,340 trading days in all.

  • 1 month-51.25%
  • 3 months-42.08%
  • Year to date-78.21%
  • 1 year-65.33%
  • 3 years-40.31%
  • 5 years-66.57%
  • Max-86.24%
See every congressional and insider trade on the CMPX price chart

Quiver Premium charts CMPX's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 1.22 1.23 1.13 1.17 1.17 7,693,255
Sep 22, 2026 1.25 1.44 1.15 1.24 1.24 27,202,788
Sep 21, 2026 1.88 1.88 1.80 1.82 1.82 2,987,340
Sep 18, 2026 1.86 1.90 1.81 1.90 1.90 8,210,036
Sep 17, 2026 1.88 1.94 1.84 1.85 1.85 2,515,917
Sep 16, 2026 1.87 1.90 1.80 1.83 1.83 2,242,999
Sep 15, 2026 1.98 1.98 1.85 1.85 1.85 2,440,059
Sep 14, 2026 2.02 2.04 1.96 1.96 1.96 2,278,976
Sep 11, 2026 2.08 2.09 1.96 2.00 2.00 4,828,614
Sep 10, 2026 2.17 2.17 2.04 2.05 2.05 2,541,061
Sep 9, 2026 2.22 2.25 2.17 2.18 2.18 2,614,911
Sep 8, 2026 2.32 2.33 2.20 2.21 2.21 2,428,040
Sep 4, 2026 2.34 2.44 2.33 2.38 2.38 2,548,324
Sep 3, 2026 2.44 2.44 2.35 2.37 2.37 2,559,952
Sep 2, 2026 2.31 2.46 2.31 2.43 2.43 2,539,819
Sep 1, 2026 2.37 2.40 2.29 2.31 2.31 1,512,903
Aug 31, 2026 2.40 2.40 2.31 2.39 2.39 3,523,042
Aug 28, 2026 2.51 2.51 2.40 2.40 2.40 2,567,637
Aug 27, 2026 2.44 2.53 2.40 2.52 2.52 1,941,408
Aug 26, 2026 2.51 2.52 2.41 2.43 2.43 1,445,009
Aug 25, 2026 2.40 2.55 2.39 2.53 2.53 2,295,274
Aug 24, 2026 2.42 2.43 2.32 2.40 2.40 974,876
Aug 21, 2026 2.39 2.45 2.33 2.40 2.40 2,032,331
Aug 20, 2026 2.42 2.46 2.31 2.36 2.36 2,179,350
Aug 19, 2026 2.42 2.52 2.41 2.48 2.48 3,903,263
Aug 18, 2026 2.27 2.44 2.24 2.39 2.39 2,934,326
Aug 17, 2026 2.20 2.37 2.20 2.31 2.31 2,369,229
Aug 14, 2026 2.30 2.30 2.23 2.25 2.25 1,362,180
Aug 13, 2026 2.36 2.37 2.23 2.26 2.26 2,272,293
Aug 12, 2026 2.20 2.38 2.17 2.37 2.37 8,291,258
Aug 11, 2026 2.20 2.38 2.20 2.20 2.20 3,984,649
Aug 10, 2026 2.15 2.23 2.11 2.22 2.22 4,205,751
Aug 7, 2026 2.05 2.17 2.03 2.15 2.15 3,827,246
Aug 6, 2026 1.93 2.00 1.87 1.99 1.99 6,688,585
Aug 5, 2026 2.00 2.01 1.85 1.89 1.89 4,253,430
Aug 4, 2026 1.90 2.00 1.89 1.98 1.98 3,050,298
Aug 3, 2026 1.94 1.95 1.85 1.89 1.89 3,511,490
Jul 31, 2026 1.95 1.96 1.86 1.91 1.91 2,640,537
Jul 30, 2026 1.93 1.96 1.91 1.94 1.94 1,913,204
Jul 29, 2026 2.04 2.04 1.94 1.94 1.94 3,176,181
Jul 28, 2026 2.07 2.08 1.97 2.04 2.04 3,147,926
Jul 27, 2026 2.11 2.23 2.08 2.08 2.08 3,401,640
Jul 24, 2026 2.12 2.14 2.06 2.07 2.07 1,589,937
Jul 23, 2026 2.02 2.14 1.99 2.12 2.12 2,266,567
Jul 22, 2026 2.09 2.11 2.00 2.04 2.04 1,771,804
Jul 21, 2026 2.02 2.10 2.01 2.10 2.10 1,620,718
Jul 20, 2026 2.07 2.12 2.01 2.02 2.02 1,906,655
Jul 17, 2026 2.06 2.12 2.01 2.05 2.05 2,143,118
Jul 16, 2026 2.13 2.15 2.07 2.10 2.10 1,760,205
Jul 15, 2026 2.18 2.19 2.11 2.14 2.14 1,685,244
Jul 14, 2026 2.25 2.26 2.18 2.19 2.19 2,013,765
Jul 13, 2026 2.30 2.31 2.19 2.26 2.26 1,879,366
Jul 10, 2026 2.30 2.36 2.19 2.33 2.33 2,797,353
Jul 9, 2026 2.33 2.36 2.27 2.31 2.31 1,972,847
Jul 8, 2026 2.26 2.35 2.21 2.34 2.34 3,881,914
Jul 7, 2026 2.30 2.32 2.15 2.32 2.32 3,212,752
Jul 6, 2026 2.27 2.30 2.20 2.29 2.29 2,481,789
Jul 2, 2026 2.20 2.29 2.17 2.27 2.27 2,939,846
Jul 1, 2026 2.18 2.21 2.13 2.18 2.18 2,379,040
Jun 30, 2026 2.16 2.29 2.13 2.19 2.19 3,888,526
Jun 29, 2026 2.08 2.17 2.07 2.16 2.16 2,836,724
Jun 26, 2026 2.06 2.12 2.02 2.08 2.08 7,606,102
Jun 25, 2026 2.03 2.11 2.02 2.07 2.07 2,518,458
Jun 24, 2026 2.06 2.10 2.02 2.02 2.02 3,137,885
Jun 23, 2026 2.04 2.11 2.04 2.06 2.06 3,107,129
Jun 22, 2026 2.04 2.10 2.02 2.10 2.10 3,390,340
Jun 18, 2026 2.08 2.13 2.00 2.02 2.02 9,276,475
Jun 17, 2026 1.99 2.14 1.99 2.05 2.05 3,744,497
Jun 16, 2026 2.01 2.04 1.96 1.97 1.97 2,532,656
Jun 15, 2026 2.05 2.10 2.02 2.04 2.04 2,174,768
Jun 12, 2026 2.00 2.08 1.98 2.03 2.03 2,049,688
Jun 11, 2026 1.91 2.04 1.88 2.01 2.01 3,589,309
Jun 10, 2026 2.06 2.10 1.91 1.92 1.92 3,521,747
Jun 9, 2026 2.04 2.10 2.03 2.06 2.06 2,327,289
Jun 8, 2026 2.04 2.07 2.00 2.02 2.02 2,267,969
Jun 5, 2026 2.10 2.12 2.03 2.04 2.04 3,144,370
Jun 4, 2026 2.07 2.17 2.07 2.13 2.13 4,479,009
Jun 3, 2026 2.08 2.11 2.04 2.10 2.10 3,508,970
Jun 2, 2026 2.13 2.17 2.06 2.08 2.08 5,189,986
Jun 1, 2026 2.31 2.32 2.18 2.22 2.22 5,708,993
May 29, 2026 2.43 2.47 2.29 2.38 2.38 6,051,262
May 28, 2026 2.23 2.44 2.16 2.41 2.41 4,832,191
May 27, 2026 2.18 2.44 2.17 2.27 2.27 6,726,136
May 26, 2026 2.04 2.23 2.01 2.20 2.20 4,729,744
May 22, 2026 1.91 2.15 1.88 2.07 2.07 5,945,503
May 21, 2026 1.84 1.99 1.84 1.93 1.93 6,576,810
May 20, 2026 1.80 1.91 1.78 1.89 1.89 3,810,361
May 19, 2026 1.80 1.84 1.75 1.81 1.81 3,731,801
May 18, 2026 1.86 1.94 1.79 1.83 1.83 4,591,742
May 15, 2026 1.93 1.96 1.85 1.86 1.86 3,874,410
May 14, 2026 1.92 2.02 1.88 1.98 1.98 5,574,862
May 13, 2026 1.88 1.99 1.83 1.97 1.97 5,385,605
May 12, 2026 1.83 1.90 1.81 1.87 1.87 5,213,525
May 11, 2026 1.78 1.91 1.77 1.83 1.83 5,811,889
May 8, 2026 1.80 1.90 1.75 1.83 1.83 6,529,812
May 7, 2026 1.86 1.87 1.75 1.81 1.81 8,770,451
May 6, 2026 1.90 1.95 1.84 1.87 1.87 11,551,812
May 5, 2026 1.95 2.00 1.84 1.95 1.95 7,685,851
May 4, 2026 2.00 2.02 1.86 1.94 1.94 13,602,120
May 1, 2026 1.79 2.01 1.75 1.96 1.96 10,661,874
Apr 30, 2026 1.69 1.82 1.67 1.77 1.77 13,524,567
Apr 29, 2026 1.91 1.91 1.64 1.67 1.67 24,705,590
Apr 28, 2026 1.91 2.18 1.79 1.84 1.84 37,557,568
Apr 27, 2026 1.77 2.48 1.61 1.79 1.79 159,018,606
Apr 24, 2026 5.22 5.49 4.89 5.03 5.03 5,058,845
Apr 23, 2026 5.32 5.34 5.11 5.21 5.21 1,079,628
Apr 22, 2026 5.36 5.39 5.22 5.32 5.32 1,848,926
Apr 21, 2026 5.42 5.58 5.19 5.24 5.24 2,735,485
Apr 20, 2026 6.11 6.24 5.41 5.42 5.42 2,761,918
Apr 17, 2026 6.60 6.67 5.87 6.00 6.00 3,732,231
Apr 16, 2026 5.87 6.84 5.81 6.53 6.53 7,118,346
Apr 15, 2026 5.48 5.92 5.38 5.85 5.85 3,192,236
Apr 14, 2026 5.20 5.47 5.14 5.44 5.44 3,542,884
Apr 13, 2026 5.18 5.25 5.00 5.20 5.20 2,348,974
Apr 10, 2026 5.45 5.50 5.00 5.17 5.17 3,158,300
Apr 9, 2026 5.32 5.59 5.30 5.45 5.45 2,686,305
Apr 8, 2026 5.50 5.59 5.29 5.40 5.40 3,059,872
Apr 7, 2026 5.45 5.53 5.20 5.31 5.31 1,624,411
Apr 6, 2026 5.47 5.73 5.46 5.49 5.49 3,197,512
Apr 2, 2026 5.25 5.50 5.18 5.45 5.45 3,183,387
Apr 1, 2026 5.41 5.51 5.11 5.43 5.43 1,912,443
Mar 31, 2026 5.26 5.38 5.06 5.29 5.29 4,366,986
Mar 30, 2026 5.21 5.24 5.07 5.10 5.10 1,281,362
Mar 27, 2026 5.29 5.37 5.15 5.21 5.21 1,355,902
Mar 26, 2026 5.41 5.67 5.30 5.33 5.33 1,327,422
Mar 25, 2026 5.42 5.56 5.39 5.49 5.49 1,366,820
Mar 24, 2026 4.96 5.39 4.87 5.33 5.33 1,850,674
Mar 23, 2026 5.16 5.29 5.00 5.04 5.04 1,634,150
Mar 20, 2026 5.40 5.44 5.14 5.15 5.15 5,577,184
Mar 19, 2026 5.27 5.40 5.19 5.39 5.39 1,992,941
Mar 18, 2026 5.41 5.41 5.23 5.32 5.32 1,487,476
Mar 17, 2026 5.39 5.54 5.31 5.45 5.45 2,570,580
Mar 16, 2026 5.24 5.53 5.20 5.41 5.41 1,467,011
Mar 13, 2026 5.27 5.36 5.07 5.19 5.19 1,058,600
Mar 12, 2026 5.50 5.59 5.18 5.19 5.19 1,465,103
Mar 11, 2026 5.60 5.70 5.48 5.59 5.59 1,454,504
Mar 10, 2026 5.49 5.78 5.42 5.57 5.57 2,248,107
Mar 9, 2026 5.34 5.54 5.29 5.42 5.42 1,897,312
Mar 6, 2026 5.41 5.53 5.29 5.51 5.51 1,845,393
Mar 5, 2026 5.53 5.87 5.43 5.53 5.53 2,823,256
Mar 4, 2026 5.59 5.88 5.54 5.69 5.69 2,080,682
Mar 3, 2026 5.50 5.86 5.43 5.53 5.53 3,173,595
Mar 2, 2026 5.44 5.81 5.32 5.68 5.68 2,281,462
Feb 27, 2026 5.73 5.83 5.61 5.65 5.65 3,697,149
Feb 26, 2026 5.93 5.94 5.60 5.78 5.78 2,722,013
Feb 25, 2026 6.00 6.07 5.81 5.89 5.89 2,242,417
Feb 24, 2026 5.93 6.03 5.84 6.00 6.00 2,051,087
Feb 23, 2026 6.15 6.20 5.75 5.89 5.89 1,799,986
Feb 20, 2026 6.31 6.43 6.14 6.17 6.17 1,359,373
Feb 19, 2026 6.43 6.50 6.25 6.39 6.39 1,456,789
Feb 18, 2026 6.37 6.60 6.30 6.47 6.47 1,465,684
Feb 17, 2026 6.25 6.55 6.23 6.39 6.39 1,290,131
Feb 13, 2026 6.53 6.60 6.21 6.28 6.28 2,517,335
Feb 12, 2026 6.44 6.50 6.26 6.34 6.34 1,575,167
Feb 11, 2026 6.60 6.67 6.29 6.44 6.44 1,611,037
Feb 10, 2026 6.79 6.82 6.52 6.60 6.60 1,328,933
Feb 9, 2026 6.50 6.82 6.40 6.69 6.69 1,373,581
Feb 6, 2026 6.35 6.68 6.29 6.52 6.52 2,008,084
Feb 5, 2026 6.27 6.56 6.20 6.22 6.22 2,172,885
Feb 4, 2026 6.65 6.67 6.25 6.33 6.33 2,596,999
Feb 3, 2026 6.59 6.88 6.25 6.42 6.42 2,461,726
Feb 2, 2026 6.39 6.71 6.38 6.52 6.52 2,385,377
Jan 30, 2026 6.29 6.47 6.21 6.40 6.40 2,839,040
Jan 29, 2026 6.17 6.44 6.06 6.38 6.38 2,666,935
Jan 28, 2026 6.45 6.49 6.05 6.16 6.16 1,569,392
Jan 27, 2026 6.16 6.48 6.13 6.41 6.41 1,798,899
Jan 26, 2026 5.85 6.21 5.69 6.19 6.19 2,835,322
Jan 23, 2026 6.25 6.35 5.89 5.90 5.90 2,342,065
Jan 22, 2026 5.93 6.40 5.92 6.27 6.27 3,646,208
Jan 21, 2026 5.71 5.96 5.63 5.90 5.90 1,921,568
Jan 20, 2026 5.60 5.80 5.50 5.71 5.71 1,022,878
Jan 16, 2026 5.82 5.85 5.55 5.70 5.70 1,769,633
Jan 15, 2026 6.11 6.25 5.62 5.80 5.80 2,922,906
Jan 14, 2026 5.57 6.17 5.43 6.04 6.04 6,449,479
Jan 13, 2026 5.18 5.62 5.15 5.58 5.58 3,318,377
Jan 12, 2026 5.37 5.44 5.08 5.21 5.21 2,530,776
Jan 9, 2026 5.20 5.70 5.16 5.35 5.35 4,347,981
Jan 8, 2026 5.41 5.41 5.13 5.17 5.17 1,780,779
Jan 7, 2026 4.92 5.57 4.92 5.45 5.45 3,104,217
Jan 6, 2026 4.91 5.05 4.79 4.91 4.91 2,406,129
Jan 5, 2026 5.36 5.36 4.85 4.99 4.99 1,594,554
Jan 2, 2026 5.36 5.41 5.04 5.17 5.17 1,441,130
Dec 31, 2025 5.37 5.45 5.19 5.37 5.37 1,834,374
Dec 30, 2025 5.22 5.38 5.06 5.38 5.38 1,663,883
Dec 29, 2025 5.10 5.22 5.05 5.15 5.15 689,533
Dec 26, 2025 5.14 5.20 5.05 5.17 5.17 946,089
Dec 24, 2025 5.18 5.20 5.03 5.14 5.14 630,988
Dec 23, 2025 5.15 5.24 5.03 5.14 5.14 1,874,756
Dec 22, 2025 5.03 5.27 5.00 5.14 5.14 1,030,236
Dec 19, 2025 5.07 5.19 4.95 4.99 4.99 8,609,233
Dec 18, 2025 5.11 5.15 4.95 5.04 5.04 1,248,180
Dec 17, 2025 5.25 5.30 4.83 4.96 4.96 2,112,723
Dec 16, 2025 5.01 5.32 5.00 5.24 5.24 1,616,824
Dec 15, 2025 5.18 5.28 5.04 5.08 5.08 1,415,206
Dec 12, 2025 5.38 5.43 5.15 5.16 5.16 1,181,778
Dec 11, 2025 5.25 5.44 5.17 5.39 5.39 1,677,898
Dec 10, 2025 5.17 5.36 5.10 5.25 5.25 1,596,232
Dec 9, 2025 5.36 5.39 5.08 5.14 5.14 1,638,887
Dec 8, 2025 5.59 5.75 5.30 5.36 5.36 1,254,066
Dec 5, 2025 5.59 5.74 5.48 5.53 5.53 1,136,265
Dec 4, 2025 5.25 5.61 5.25 5.54 5.54 1,474,322
Dec 3, 2025 5.39 5.39 5.17 5.28 5.28 2,065,461
Dec 2, 2025 5.60 5.65 5.13 5.22 5.22 1,905,683
Dec 1, 2025 5.84 5.86 5.33 5.46 5.46 3,199,809
Nov 28, 2025 5.51 5.84 5.45 5.80 5.80 1,525,413
Nov 26, 2025 5.09 5.39 4.96 5.39 5.39 3,183,103
Nov 25, 2025 4.99 5.03 4.73 5.01 5.01 2,718,455
Nov 24, 2025 4.95 5.16 4.92 4.95 4.95 2,330,289
Nov 21, 2025 4.85 5.00 4.81 4.87 4.87 2,511,335
Nov 20, 2025 4.94 5.07 4.79 4.85 4.85 1,041,079
Nov 19, 2025 4.93 5.11 4.90 4.90 4.90 1,096,060
Nov 18, 2025 4.86 5.05 4.83 4.93 4.93 2,156,733
Nov 17, 2025 4.87 5.05 4.77 4.89 4.89 2,555,239
Nov 14, 2025 4.66 5.03 4.62 4.83 4.83 1,525,773
Nov 13, 2025 4.90 4.92 4.69 4.77 4.77 1,722,686
Nov 12, 2025 4.61 5.05 4.54 4.90 4.90 1,927,353
Nov 11, 2025 4.22 4.68 4.22 4.63 4.63 4,529,306
Nov 10, 2025 4.24 4.36 4.07 4.28 4.28 2,333,278
Nov 7, 2025 4.00 4.24 3.81 4.23 4.23 2,456,243
Nov 6, 2025 3.82 4.10 3.78 4.00 4.00 1,678,969
Nov 5, 2025 3.82 3.90 3.49 3.82 3.82 2,896,429
Nov 4, 2025 3.69 3.89 3.67 3.79 3.79 1,587,948
Nov 3, 2025 3.77 3.95 3.65 3.74 3.74 1,081,381
Oct 31, 2025 3.72 3.84 3.63 3.74 3.74 2,290,325
Oct 30, 2025 3.74 3.85 3.68 3.72 3.72 867,940
Oct 29, 2025 4.08 4.08 3.77 3.78 3.78 1,630,829
Oct 28, 2025 4.09 4.26 3.99 4.10 4.10 923,089
Oct 27, 2025 3.98 4.20 3.95 4.11 4.11 1,351,925
Oct 24, 2025 3.90 4.11 3.89 3.97 3.97 843,127
Oct 23, 2025 4.14 4.17 3.85 3.89 3.89 1,227,561
Oct 22, 2025 4.06 4.21 3.88 4.16 4.16 6,641,121
Oct 21, 2025 4.05 4.26 4.00 4.10 4.10 1,244,226
Oct 20, 2025 4.28 4.37 4.01 4.05 4.05 1,420,915
Oct 17, 2025 4.35 4.46 4.15 4.26 4.26 1,841,660
Oct 16, 2025 4.77 4.86 4.43 4.52 4.52 1,526,962
Oct 15, 2025 4.34 4.78 4.34 4.77 4.77 2,075,079
Oct 14, 2025 4.20 4.38 4.12 4.34 4.34 588,757
Oct 13, 2025 4.25 4.39 4.06 4.29 4.29 1,581,768
Oct 10, 2025 4.07 4.31 4.00 4.24 4.24 2,417,406
Oct 9, 2025 3.88 4.09 3.84 4.07 4.07 1,681,827
Oct 8, 2025 3.61 3.92 3.55 3.90 3.90 1,785,380
Oct 7, 2025 3.67 3.68 3.52 3.61 3.61 1,809,188
Oct 6, 2025 3.80 3.80 3.44 3.67 3.67 2,120,980
Oct 3, 2025 3.47 3.71 3.46 3.70 3.70 1,584,581
Oct 2, 2025 3.37 3.50 3.36 3.47 3.47 1,362,471
Oct 1, 2025 3.50 3.52 3.31 3.36 3.36 2,688,018
Sep 30, 2025 3.79 3.83 3.48 3.50 3.50 2,814,281
Sep 29, 2025 3.75 3.82 3.67 3.82 3.82 1,076,199
Sep 26, 2025 3.49 3.77 3.43 3.74 3.74 1,520,291
Sep 25, 2025 3.49 3.58 3.41 3.49 3.49 1,170,362
Sep 24, 2025 3.41 3.54 3.38 3.49 3.49 1,110,565
Sep 23, 2025 3.50 3.60 3.37 3.38 3.38 1,528,012

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Compass Therapeutics, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at CMPX, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation